phenyl biguanide and 1-(3-chlorophenyl)piperazine

phenyl biguanide has been researched along with 1-(3-chlorophenyl)piperazine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Rahman, AA; Dukat, M; Glennon, RA; Gyermek, L; Ingher, S; Ismaiel, AM; Teitler, M1
Ireland, SJ; Tyers, MB1
Calama, E; Martín, ML; Morán, A; Ortíz de Urbina, AV; San Román, L1

Other Studies

3 other study(ies) available for phenyl biguanide and 1-(3-chlorophenyl)piperazine

ArticleYear
Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors.
    Journal of medicinal chemistry, 1996, Sep-27, Volume: 39, Issue:20

    Topics: Animals; Biguanides; Heart Rate; Male; Molecular Structure; Muscle Contraction; Piperazines; Rabbits; Rats; Receptors, Serotonin; Reflex; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Urinary Bladder

1996
Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve.
    British journal of pharmacology, 1987, Volume: 90, Issue:1

    Topics: Animals; Biguanides; Cocaine; In Vitro Techniques; Male; Piperazines; Quipazine; Rats; Serotonin; Serotonin Antagonists; Vagus Nerve

1987
Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
    Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:10

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Biguanides; Biphenyl Compounds; Dose-Response Relationship, Drug; Electric Stimulation; Hindlimb; In Vitro Techniques; Infusions, Intravenous; Male; Methiothepin; Oxadiazoles; Perfusion; Piperazines; Pressure; Quinoxalines; Rats; Rats, Wistar; Ritanserin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT3 Receptor Agonists; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines; Vasoconstriction

2005